Cargando…

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—No

Detalles Bibliográficos
Autores principales:	Olivier, Jonathan, Konety, Badrinath, Hayne, Dickon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Open to Debate Con
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385288/ https://www.ncbi.nlm.nih.gov/pubmed/34467235 http://dx.doi.org/10.1016/j.euros.2021.06.012

Ejemplares similares

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee
por: van den Bergh, Roderick C.N., et al.
Publicado: (2021)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
por: Grummet, Jeremy P., et al.
Publicado: (2021)

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
por: Grummet, Jeremy, et al.
Publicado: (2020)

Stage II Seminoma: Why Chemotherapy Should Remain a Standard
por: Naoun, Natacha, et al.
Publicado: (2023)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?
por: Moe, Andrew, et al.
Publicado: (2020)

Advantages of an Intracorporeal W-shaped Neobladder
por: Nouhaud, François-Xavier, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Cytoreductive Nephrectomy in 2021: Obsolete
por: Meza, Luis, et al.
Publicado: (2021)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended? Of Course Not!
por: Sooriakumaran, Prasanna, et al.
Publicado: (2022)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con
por: Kuusk, Teele, et al.
Publicado: (2022)

Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips or Low-energy Bipolar Coagulation? Low Energy
por: de la Taille, Alexandre
Publicado: (2022)

Thulium YAG is the Best Laser for the Prostate Because of Versatility
por: Herrmann, Thomas R.W., et al.
Publicado: (2022)

How To Manage T3b Prostate Cancer in the Contemporary Era: The Benefits of Surgery
por: Peyrottes, Arthur, et al.
Publicado: (2023)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Japan should initiate the discussion on voluntary assisted dying legislation now
por: Asai, Atsushi, et al.
Publicado: (2023)

Debate: Why should gender-affirming health care be included in health science curricula?
por: de Vries, Elma, et al.
Publicado: (2020)

Dyslexia debated, then and now: a historical perspective on the dyslexia debate
por: Kirby, Philip
Publicado: (2020)

Debate. How should steps per day be reported--a proposal using data from Africa
por: Cook, Ian
Publicado: (2012)

Ether in the developing world: rethinking an abandoned agent
por: Chang, Connie Y., et al.
Publicado: (2015)

Debate: should we use variable adjusted life displays (VLAD) to identify variations in performance in general surgery?
por: O´Neill, Stephen, et al.
Publicado: (2015)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
por: White, Nicholas J.
Publicado: (2019)

Pro con debates in clinical medicine infection prevention and control in cystic fibrosis: One size fits all? The argument in favour
por: Haggie, S., et al.
Publicado: (2020)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
por: Krishna, Sanjeev
Publicado: (2019)

Reframing a debate in chiropractic
por: Pollard, Henry
Publicado: (2021)

Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: primum non nocere!
por: Rossignol, Patrick, et al.
Publicado: (2023)

Adaptive reuse in the healthcare industry: repurposing abandoned buildings to serve medical missions
por: Elrod, James K., et al.
Publicado: (2017)

Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023)

Open science versus commercialization: a modern research conflict?
por: Caulfield, Timothy, et al.
Publicado: (2012)

An ethics safe harbor for international genomics research?
por: Dove, Edward S, et al.
Publicado: (2013)

Harvard Personal Genome Project: lessons from participatory public research
por: Ball, Madeleine P, et al.
Publicado: (2014)

Disentangling Public Participation In Science and Biomedicine
por: Kelty, Christopher, et al.
Publicado: (2014)

Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis(® )compared to Genentech's Herceptin(®)
por: Baldwin, A Lane, et al.
Publicado: (2013)

Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy
por: Sayres, Lauren C, et al.
Publicado: (2012)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

How To Deal with Renal Cell Carcinoma Tumors >7 cm: The Role of Nephron-sparing Surgery
por: Minervini, Andrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_alm7af0ll9rat93bi2e76p9vnc